BioXcel Therapeutics Inc (NASDAQ: BTAI) started the day on Wednesday, with a price increase of 17.24% at $2.04, before settling in for the price of $1.74 at the close. Taking a more long-term approach, BTAI posted a 52-week range of $1.17-$9.14.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 6.20%. Meanwhile, its Annual Earning per share during the time was 6.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 72.31%. This publicly-traded company’s shares outstanding now amounts to $21.87 million, simultaneously with a float of $21.02 million. The organization now has a market capitalization sitting at $44.61 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8900, while the 200-day Moving Average is $2.2800.
BioXcel Therapeutics Inc (BTAI) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. BioXcel Therapeutics Inc’s current insider ownership accounts for 3.89%, in contrast to 10.78% institutional ownership.
BioXcel Therapeutics Inc (BTAI) Earnings and Revenue Records
BioXcel Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 72.31% and is forecasted to reach -3.10 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 55.37% through the next 5 years, which can be compared against the 6.20% growth it accomplished over the previous five years trading on the market.
BioXcel Therapeutics Inc (NASDAQ: BTAI) Trading Performance Indicators
Let’s observe the current performance indicators for BioXcel Therapeutics Inc (BTAI). It’s Quick Ratio in the last reported quarter now stands at 1.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 59.48.
In the same vein, BTAI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -9.70, a figure that is expected to reach -0.71 in the next quarter, and analysts are predicting that it will be -3.10 at the market close of one year from today.
Technical Analysis of BioXcel Therapeutics Inc (BTAI)
If we take a close look at the recent performances of BioXcel Therapeutics Inc (NASDAQ: BTAI), its last 5-days Average volume was 0.85 million that shows plunge from its year to date volume of 0.93 million. During the previous 9 days, stock’s Stochastic %D was recorded 84.72% While, its Average True Range was 66.63.
Raw Stochastic average of BioXcel Therapeutics Inc (BTAI) in the period of the previous 100 days is set at 10.09%, which indicates a major fall in contrast to 87.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1200 that was lower than 0.2600 volatility it exhibited in the past 100-days period.
